TMCI vs TMO · rev $92.6M vs P/E 24, rev $23.00B
Treace Medical Concepts Inc (TMCI) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported TMCI revenue for 2026-06-30 was $92.6M. Net income was -$33.8M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. TMCI currently screens at market cap $260.1M.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
TMCI currently screens at market cap $260.1M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the TMCI and TMO stock pages for the full models.
Not investment advice.